{"id":"https://openalex.org/W2000972011","doi":"https://doi.org/10.1158/1538-7445.am2011-lb-201","title":"Abstract LB-201: New derivatives of etoposide show promise as more potent inhibitors of cancer cell growth","display_name":"Abstract LB-201: New derivatives of etoposide show promise as more potent inhibitors of cancer cell growth","publication_year":2011,"publication_date":"2011-04-01","ids":{"openalex":"https://openalex.org/W2000972011","doi":"https://doi.org/10.1158/1538-7445.am2011-lb-201","mag":"2000972011"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2011-lb-201","doi":"https://doi.org/10.1158/1538-7445.am2011-lb-201","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-lb-201","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024756657","display_name":"Susannah Gal","orcid":"https://orcid.org/0000-0001-5422-7807","observed_orcids":["https://orcid.org/0000-0001-5422-7807"]},"institutions":[{"id":"https://openalex.org/I123946342","display_name":"Binghamton University","ror":"https://ror.org/008rmbt77","country_code":"US","type":"education","lineage":["https://openalex.org/I123946342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susannah Gal","raw_affiliation_strings":["1Binghamton Univ., Binghamton, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Binghamton Univ., Binghamton, NY","institution_ids":["https://openalex.org/I123946342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032702979","display_name":"Rebecca S. Young","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123946342","display_name":"Binghamton University","ror":"https://ror.org/008rmbt77","country_code":"US","type":"education","lineage":["https://openalex.org/I123946342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca Young","raw_affiliation_strings":["1Binghamton Univ., Binghamton, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Binghamton Univ., Binghamton, NY","institution_ids":["https://openalex.org/I123946342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027072098","display_name":"Steve N. Slilaty","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steve Slilaty","raw_affiliation_strings":["2Sunshine Biopharma Inc, Montreal, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Sunshine Biopharma Inc, Montreal, Quebec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082374564","display_name":"G\u00e9raldine Castelot-Deliencourt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Geraldine Deliencourt-Godefroy","raw_affiliation_strings":["3TFChem, Val de Reuil, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3TFChem, Val de Reuil, France","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112444828","display_name":"Jean\u2010Charles Quirion","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I88814501","display_name":"Institut National des Sciences Appliqu\u00e9es Rouen Normandie","ror":"https://ror.org/020ws7586","country_code":"FR","type":"education","lineage":["https://openalex.org/I4210105918","https://openalex.org/I88814501"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Charles Quirion","raw_affiliation_strings":["4Institut National des Sciences Appliquees de Rouen, Mont Saint-Aignan, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Institut National des Sciences Appliquees de Rouen, Mont Saint-Aignan, France","institution_ids":["https://openalex.org/I88814501"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"71","issue":"8_Supplement","first_page":"LB","last_page":"201"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13105","display_name":"Synthesis and pharmacology of benzodiazepine derivatives","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/topoisomerase-ii-inhibitors","display_name":"topoisomerase II inhibitors","score":0.9700000286102295},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.7459999918937683},{"id":"https://openalex.org/keywords/reversal-of-drug-resistance","display_name":"drug resistance reversal","score":0.46299999952316284},{"id":"https://openalex.org/keywords/tumor-cell-growth-inhibition","display_name":"tumor cell growth inhibition","score":0.8050000071525574},{"id":"https://openalex.org/keywords/anthracycline-toxicity","display_name":"anthracycline toxicity","score":0.7269999980926514}],"concepts":[{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.8887737989425659},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.7657197713851929},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.49786806106567383},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.4900273084640503},{"id":"https://openalex.org/C2778616834","wikidata":"https://www.wikidata.org/wiki/Q281044","display_name":"Topoisomerase inhibitor","level":4,"score":0.46439793705940247},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4405781030654907},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.424932062625885},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.42154693603515625},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.41890212893486023},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33600568771362305},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.319590300321579},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3143826723098755},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.23458966612815857},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2110307216644287},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18701651692390442}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2011-lb-201","doi":"https://doi.org/10.1158/1538-7445.am2011-lb-201","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-lb-201","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2108182487","https://openalex.org/W1786775917","https://openalex.org/W2404885310","https://openalex.org/W7168144815","https://openalex.org/W1984824591","https://openalex.org/W2914220504","https://openalex.org/W2051907464","https://openalex.org/W2347702013","https://openalex.org/W1977740423","https://openalex.org/W3186116012"],"abstract_inverted_index":{"Abstract":[0],"The":[1,26,190],"DNA":[2],"repair":[3],"enzyme":[4],"Topoisomerase":[5],"II":[6],"(TopoII)":[7],"has":[8,60],"been":[9,127],"recognized":[10,61],"in":[11,39,129,195],"the":[12,43,51,63,76,83,100,162,175,179,198,220,225,251,256],"oncology":[13],"field":[14],"as":[15,31,88],"a":[16,22,80,89,94,106,140,149],"clinically":[17],"important":[18],"therapeutic":[19],"target":[20,38],"for":[21,233,259],"variety":[23,141],"of":[24,28,46,54,69,75,82,142,153,178,219,222,224,236,250,255],"cancers.":[25],"class":[27,53],"agents":[29],"known":[30],"etoposides":[32],"were":[33],"specifically":[34],"designed":[35],"with":[36,50,174,184,209],"this":[37,170],"mind.":[40],"Etoposides":[41],"lacked":[42],"major":[44],"problem":[45],"cardiac":[47],"toxicity":[48,68],"associated":[49,183,208],"anthracyclines":[52],"drugs":[55,122,238],"(e.g.":[56],"doxorubicin).":[57],"Sunshine":[58],"Biopharma":[59],"that":[62,194],"reduced":[64],"efficacy":[65],"and":[66,110,119,123,159,231],"high":[67],"etoposide":[70,217],"are":[71,166],"due":[72],"to":[73,79,104,157,169,187],"instability":[74],"molecule":[77],"leading":[78],"conversion":[81],"drug":[84],"which":[85],"then":[86],"functions":[87],"tubulin":[90],"inhibitor":[91,96,109,152],"rather":[92],"than":[93],"TopoII":[95,108],"(unpublished":[97],"observations).":[98],"Accordingly,":[99],"company":[101],"set":[102],"out":[103],"develop":[105],"true":[107],"these":[111,237],"efforts":[112],"have":[113,126],"yielded":[114],"two":[115],"compounds":[116],"called":[117],"Adva-27a":[118,145,215],"Adva-32a.":[120],"These":[121],"their":[124],"derivatives":[125],"described":[128],"US":[130],"Patent":[131],"Application":[132],"Number:":[133],"20090318675.":[134],"Using":[135],"cell":[136,154,201,227],"lines":[137],"derived":[138],"from":[139],"human":[143],"cancers,":[144],"is":[146,182,207],"almost":[147],"always":[148],"more":[150],"potent":[151],"growth":[155,188],"compared":[156],"etoposide,":[158],"cells":[160],"expressing":[161],"MDR-drug":[163],"resistance":[164],"protein":[165],"very":[167],"sensitive":[168],"drug.":[171],"Furthermore,":[172],"consistent":[173],"literature,":[176],"amplification":[177],"TOP2\u03b1":[180,204],"gene":[181],"increased":[185,203],"sensitivity":[186],"inhibition.":[189],"preliminary":[191],"data":[192,230],"show":[193],"all":[196],"but":[197],"brain":[199],"tumor":[200,226],"line,":[202],"copy":[205],"number":[206],"even":[210],"greater":[211],"percent":[212],"inhibition":[213],"by":[214],"versus":[216],"regardless":[218],"tissue":[221],"origin":[223],"lines.":[228],"This":[229],"plans":[232],"further":[234],"analysis":[235],"will":[239],"be":[240],"presented.":[241],"Citation":[242],"Format:":[243],"{Authors}.":[244],"{Abstract":[245],"title}":[246],"[abstract].":[247],"In:":[248],"Proceedings":[249],"102nd":[252],"Annual":[253],"Meeting":[254],"American":[257],"Association":[258],"Cancer":[260,270],"Research;":[261],"2011":[262],"Apr":[263],"2-6;":[264],"Orlando,":[265],"FL.":[266],"Philadelphia":[267],"(PA):":[268],"AACR;":[269],"Res":[271],"2011;71(8":[272],"Suppl):Abstract":[273],"nr":[274],"LB-201.":[275],"doi:10.1158/1538-7445.AM2011-LB-201":[276]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}